Cart (0 Items)
Your cart is currently empty.
View ProductsBrand | ProteoGenix |
---|---|
Product type | Elisa assay kits |
Size | 96T |
Product name | Amatuximab ELISA Kit |
---|---|
Delivery condition | Blue ice (+4°) |
Storage condition | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
Brand | ProteoGenix |
Size | 96T |
Reference | KPTX246 |
Note | For research use only. |
Sample type | Plasma, Serum |
Immunogen | Amatuximab |
Introduction
Amatuximab, also known as MORAb-009, is a monoclonal antibody that has shown promising results in the treatment of various types of cancer. It specifically targets mesothelin, a protein that is overexpressed in many types of cancer cells. The Amatuximab ELISA Kit is a valuable tool for researchers and clinicians to measure the levels of Amatuximab in patient samples and monitor its activity.
Structure of Amatuximab
Amatuximab is a chimeric monoclonal antibody, meaning it is composed of both human and mouse components. It is made up of two heavy chains and two light chains, with a total molecular weight of approximately 150 kDa. The heavy chains are composed of constant and variable regions, while the light chains only have variable regions. The variable regions are responsible for binding to the target protein, mesothelin.
Activity of Amatuximab
As mentioned earlier, Amatuximab specifically targets mesothelin, a protein that is highly expressed in various types of cancer cells. Mesothelin is a glycoprotein that is normally found on the surface of mesothelial cells, but its expression is significantly increased in cancer cells. Amatuximab binds to mesothelin with high affinity, blocking its activity and preventing its interaction with other proteins. This results in inhibition of cancer cell growth and induction of cell death, making Amatuximab a promising therapeutic agent for cancer treatment.
Application of Amatuximab ELISA Kit
The Amatuximab ELISA Kit is a valuable tool for measuring the levels of Amatuximab in patient samples. It is a highly sensitive and specific assay that utilizes the sandwich ELISA technique. The kit contains all the necessary reagents and materials for the quantification of Amatuximab, including pre-coated microplates, detection and capture antibodies, and standards. The procedure is simple and can be completed within a few hours, making it suitable for high-throughput analysis.
The Amatuximab ELISA Kit has various applications in both research and clinical settings. In research, it can be used to evaluate the pharmacokinetics and pharmacodynamics of Amatuximab, as well as its efficacy in different cancer models. It can also be used to study the expression levels of mesothelin in various cancer types and its correlation with Amatuximab response. In clinical settings, the kit can be used to monitor Amatuximab levels in patient samples, ensuring proper dosing and treatment efficacy. It can also be used as a diagnostic tool to determine the presence of mesothelin in cancer patients, which can help in patient selection for Amatuximab treatment.
Advantages of Amatuximab ELISA Kit
The Amatuximab ELISA Kit offers several advantages over other methods of Amatuximab detection. First and foremost, it is highly specific and sensitive, allowing for accurate quantification of Amatuximab levels in patient samples. It also has a wide dynamic range, making it suitable for measuring both high and low concentrations of Amatuximab. The kit is also cost-effective and time-efficient, making it a preferred choice for researchers and clinicians.
Conclusion
The Amatuximab ELISA Kit is a valuable tool for measuring the levels of Amatuximab in patient samples. It is a highly specific and sensitive assay that utilizes the sandwich ELISA technique. Amatuximab, a chimeric monoclonal antibody, specifically targets mesothelin, a protein that is overexpressed in many types of cancer cells. The Amatuximab ELISA Kit has various applications in research and clinical settings, making it a valuable asset in the development and monitoring of Amatuximab as a therapeutic agent for cancer treatment.
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.